Organization

Elpiscience (Suzhou) Biopharma

2 clinical trials

Clinical trial

Phase I/II Clinical Trial of ES104 in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer Who Have Failed Systemic Therapies

Status: Active (not recruiting), Estimated PCD: 2026-05-31

Clinical trial

An Open-label, Multicenter, Dose-escalation and Cohort Expansion Phase 1 Clinical Study of ES014 Administered in Patients Locally Advanced or Metastatic Solid Tumours

Status: Recruiting, Estimated PCD: 2025-06-30